{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:14:16Z","timestamp":1790118856097,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.nmd.2009.08.015","type":"journal-article","created":{"date-parts":[[2009,9,21]],"date-time":"2009-09-21T04:10:23Z","timestamp":1253506223000},"page":"779-783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Rippling muscle disease and cardiomyopathy associated with a mutation in the CAV3 gene"],"prefix":"10.1016","volume":"19","author":[{"given":"Michela","family":"Catteruccia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Maria","family":"Santorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Tessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella Di","family":"Giacopo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Sauchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Verbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Lo","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serenella","family":"Servidei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2009.08.015_bib1","doi-asserted-by":"crossref","first-page":"15160","DOI":"10.1074\/jbc.271.25.15160","article-title":"Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins","volume":"21","author":"Song","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2009.08.015_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1471-4914(01)02105-0","article-title":"Caveole and caveolin-3 in muscular dystrophy","volume":"7","author":"Galbiati","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.nmd.2009.08.015_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1091\/mbc.6.7.911","article-title":"VIP21-caveolin, a membrane protein constituent of the caveolar coat, oligomerizes in vivo and in vitro","volume":"6","author":"Monier","year":"1995","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.nmd.2009.08.015_bib4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng0498-365","article-title":"Mutations in the caveolin-3 gene cause autosomal dominant limb girdle muscular dystrophy","volume":"18","author":"Minetti","year":"1998","journal-title":"Nat Gen"},{"key":"10.1016\/j.nmd.2009.08.015_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/90050","article-title":"Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease","volume":"28","author":"Betz","year":"2001","journal-title":"Nat Gen"},{"key":"10.1016\/j.nmd.2009.08.015_bib6","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1212\/WNL.54.6.1373","article-title":"Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia","volume":"54","author":"Carbone","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2009.08.015_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/WNL.58.2.323","article-title":"Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy","volume":"58","author":"Tateyama","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2009.08.015_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbrc.2003.11.101","article-title":"Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy","volume":"313","author":"Hayashi","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nmd.2009.08.015_bib9","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.106.635268","article-title":"Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome","volume":"114","author":"Vatta","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.nmd.2009.08.015_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.hrthm.2006.11.030","article-title":"Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3","volume":"4","author":"Cronk","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.nmd.2009.08.015_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/jnnp.2007.133207","article-title":"Truncation of caveolin-3 causes autosomal-recessive rippling muscle disease","volume":"79","author":"Traverso","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2009.08.015_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ana.10442","article-title":"Consequences of a novel caveolin-3 mutation in a large German family","volume":"53","author":"Fischer","year":"2003","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nmd.2009.08.015_bib13","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.nmd.2006.04.006","article-title":"Novel splice site mutation in the caveolin-3 gene leading to autosomal recessive limb girdle muscular dystrophy","volume":"16","author":"M\u00fcller","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2009.08.015_bib14","doi-asserted-by":"crossref","first-page":"38988","DOI":"10.1074\/jbc.M205511200","article-title":"Caveolin-3 knock out mice develop a progressive cardiomyopathy and show hyperactivation of the p42\/44 MAPK cascade","volume":"277","author":"Woodman","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2009.08.015_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/hmg\/ddh014","article-title":"Over-expression of P104L mutant caveolin-3 in mice develops hypertrophic cardiomyopathy with enhanced contractility in association with increased endothelial nitric oxide synthase activity","volume":"13","author":"Ohsawa","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2009.08.015_bib16","doi-asserted-by":"crossref","first-page":"22810","DOI":"10.1074\/jbc.271.37.22810","article-title":"Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells","volume":"271","author":"Feron","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2009.08.015_bib17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/372546a0","article-title":"Nitric oxide in skeletal muscle","volume":"372","author":"Kobzik","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2009.08.015_bib18","doi-asserted-by":"crossref","first-page":"28187","DOI":"10.1074\/jbc.272.45.28187","article-title":"Interaction of neuronal nitric oxide synthase with caveolin-3 in skeletal muscle. Identification of a novel caveolin scaffolding\/inhibitory domain","volume":"272","author":"Venema","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2009.08.015_bib19","doi-asserted-by":"crossref","first-page":"20698","DOI":"10.1074\/jbc.272.33.20698","article-title":"Association of phosphofructokinase-M with caveolin-3 in differentiated skeletal myotubes: dynamic regulation by extracellular glucose and intracellular metabolites","volume":"272","author":"Scherer","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2009.08.015_bib20","doi-asserted-by":"crossref","first-page":"31036","DOI":"10.1074\/jbc.M502540200","article-title":"G-protein-coupled receptor signaling components localize in both sarcolemmal and intracellular caveolin-3-associated microdomains in adult cardiac myocytes","volume":"280","author":"Head","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2009.08.015_bib21","doi-asserted-by":"crossref","first-page":"23738","DOI":"10.1074\/jbc.M212892200","article-title":"Caveolin interacts with the angiotensin II type 1 receptor during exocytic transport but not at the plasma membrane","volume":"278","author":"Wyse","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nmd.2009.08.015_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/01.HYP.0000082926.08268.5D","article-title":"Adenovirus-mediated overexpression of caveolin-3 inhibits rat cardiomyocyte hypertrophy","volume":"42","author":"Koga","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.nmd.2009.08.015_bib23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/labinvest.3700713","article-title":"Caveolin-3 T78M and T78K missense mutations lead to different phenotypes in vivo and in vitro","volume":"8","author":"Traverso","year":"2008","journal-title":"Lab Invest"},{"key":"10.1016\/j.nmd.2009.08.015_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.CIR.0000078641.19365.4C","article-title":"Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance","volume":"108","author":"McCrohon","year":"2003","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.nmd.2009.08.015_bib25","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","article-title":"Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy","volume":"48","author":"Assomull","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nmd.2009.08.015_bib26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pbiomolbio.2009.01.012","article-title":"Caveolae, ion channels and cardiac arrhythmias","volume":"98","author":"Balijepalli","year":"2008","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/j.nmd.2009.08.015_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/humu.20119","article-title":"Molecular and muscle pathology in a series of caveolinopathy patients","volume":"25","author":"Fulizio","year":"2005","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2009.08.015_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archneur.1989.00520400065020","article-title":"Rippling muscle disease","volume":"46","author":"Ricker","year":"1989","journal-title":"Arch Neurol"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896609005926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896609005926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:57:37Z","timestamp":1760774257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896609005926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0960896609005926"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2009.08.015","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rippling muscle disease and cardiomyopathy associated with a mutation in the CAV3 gene","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2009.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}